http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103596566-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D261-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D261-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 |
| filingDate | 2011-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103596566-B |
| titleOfInvention | Polycyclic LPA1Antagonist and its use |
| abstract | There is described herein LPA 1 Antagonist 1 { 4'[3 methyl 4 (base of (R) 1 phenylethoxycarbonyl amino) isoxazoles 5] 4 base of xenyl } cyclopropane-carboxylic acid (compound 1) or its pharmaceutically acceptable salt.It is described herein and prepares the LPA1 antagonists or its pharmaceutically-acceptable salts and contain the LPA suitable for what is be administered to mammal 1 The method of the pharmaceutical composition of antagonist or its pharmaceutically-acceptable salts and the method that LPA dependences or the disease or sufferer of LPA mediations are treated using this pharmaceutical composition. |
| priorityDate | 2010-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 2253.